WASHINGTON D.C., DC — More protections against drug shortages could be on the way, as Virginia Sen. Tim Kaine and Arkansas Sen. Tom Cotton teamed up for the Protect Our Essential Medicines Act. If ...
Senators introduced legislation on Thursday that would require prescription drug labels to identify where the medication was made, adding momentum to a yearslong campaign to bring more transparency to ...
Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges. In this episode, Kristi Martin, a longtime Washington, DC–based policy ...
FIRST ON FOX: A bipartisan group of lawmakers is pushing to reform the incentive structure for Pharmacy Benefit Managers (PBMs), arguing that it drives up patient costs by encouraging them to favor ...
The Inflation Reduction Act (IRA) of 2022 allowed the Centers for Medicare and Medicaid Services to begin negotiating prices for certain prescription drugs in Medicare. For products to be eligible, ...
Recently, the Virginia General Assembly took a big step in lowering prescription drug prices. A bipartisan bill passed both the House and the Senate that would create a board to oversee prescription ...
US taxpayers provide enormous contributions to global biomedical research and drug development, investing $54 billion in 2023. Yet, US patients also face the highest brand-name drug prices in the ...
The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend an Inflation Reduction Act (IRA) provision currently affecting treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results